HYDRATING CC CREAM FOR RADIANT-LOOKING SKIN

Croda Singapore
Although formulated as a water-in-oil emulsion, this CC Cream is surprisingly light and non-greasy. Crodamol ISIS synergistically interacts with stratum corneum lipids, leading to an increase in barrier performance and moisturisation without being occlusive. Solaveil XT-100 offers unprecedented broad spectrum protection and a light, elegant skin feel.
Phase
Product
INCI Name
Supplier
Volume
A
DEIONISED WATER
to 100
MAGNESIUM SULFATE HEPTAHYDRATE
5.00
B
SOLAVEILTM XT-1001
TITANIUM DIOXIDE (AND) C12-15 ALKYL BENZOATE (AND) POLYHYDROXYSTEARIC ACID (AND) STEARIC ACID (AND) ALUMINA
6.00
CRODAMOLTM ISIS1
ISOSTEARYL ISOSTEARATE
3.00
CITHROL™ DPHS1
PEG-30 DIPOLYHYDROXYSTEARATE
2.00
DC 345 FLUID2
CYCLOMETHICONE
6.00
ETHYHEXYL METHOXYCINNAMATE3
6.00
ETHYHEXYL SALICYLATE3
5.00
ULTRAFINE TITANIUM DIOXIDE4
4.00
C
PRICERINETM 90911
GLYCERIN
4.00
YELLOW IRON OXIDE
0.50
RED IRON OXIDE
0.15
BLACK IRON OXIDE
0.06
D
MICROCARE MTC5
METHYLISOTHIAZOLINONE (AND) CHLORPHENESIN
1.00
PHYTESSENSETM PURPLE GINSENG
GLYCERIN (AND) WATER AND)ALCOHOL (AND)POLYGONUM BISTORTA ROOT EXTRACT
5.00

Preparation:

1. Combine water phase (Part A) ingredients and heat to 80oC. 2. Separately, combine oil phase (Part B) and heat to 80oC. 3. Slowly add Part A to Part B with intensive stirring. 4. Combine Part C and add into the system. 5. Homogenise for 2 minute at 10,000 rpm (for 100 g batch). 6. Stir to cool. Add Part D.

Notes:

Suppliers: - 1: Croda 2: Dow Corning 3: Merck 4: Kemira 5: Thor Appearance: Brown cream pH 5.5-6.0 Viscosity: 18,150 cPs (DV-II+, spindle 6, 20rpm at 1 min) Stability: Passed 3 months @ RT & 40oC; Passed 1 month @ 50oC In-vitro SPF: 22 In-Vitro UVA Protection: PA+ In-Vitro testing services provided by Croda Singapore Pte Ltd
Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

IFSCC 2024

Recanto das Cataratas Thermas Resort, Iguazu Falls, Brazil
14th - 17th October 2024

SEPAWA

Estrel Congress Center, Berlin
16th - 18th October 2024